Helicase-primase inhibitors for the treatment of herpes simplex virus infections – patent evaluation of WO2023/225162 from gilead sciences inc

Helicase-primase is an interesting target for small molecule therapy of herpes simplex virus (HSV) infections. With amenamevir already approved for varicella-zoster virus and herpes simplex in Japan and with